IL2 and neoplasm: The combinatorial treatment of resistant NB with DB and FAP-IL-2 in vivo effectively inhibited tumor growth, improved the survival of tumor-bearing mice and resulted in an increase in cytotoxic T and NK cells, as well as a reduction in Treg found in tumor tissue.